Acrivon Therapeutics Q1 2026 Earnings Narrower Loss Per Share as Pipeline Progress Continues MBIA Q1 2026 Earnings Significant EPS Miss Reflects Operating Challenges Leidos Q1 2026 Earnings EPS Beat with 586 Surprise Shares Rise ColgatePalmolive Q1 2026 Earnings Slight EPS Miss Amid Positive Stock Movement MCRB Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Development Activities Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development